Loading...
Non-ion channel therapeutics for heart failure and atrial fibrillation: are CaMKII inhibitors ready for clinical use?
The Ca(2+)-calmodulin dependent protein kinase II (CaMKII) is an established central mediator of electrophysiological and contractile responses to cardiac stress, and its hyper-activation in cardiac diseases has been linked to heart failure (HF) and atrial and ventricular arrhythmias. Here we summar...
Na minha lista:
| Udgivet i: | J Mol Cell Cardiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6358017/ https://ncbi.nlm.nih.gov/pubmed/29079077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yjmcc.2017.10.010 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|